Topotecan Injection IP

Key Benefits
- Used in the treatment of certain ovarian cancers
- Helps manage small-cell lung cancer in appropriate patients
- Used for certain advanced or recurrent cervical cancers
- Helps inhibit the growth and multiplication of cancer cells
- Provides targeted interference with cancer-cell DNA replication
How It Works
Topotecan inhibits topoisomerase I, an enzyme required for DNA replication and repair. By interfering with this process, it causes DNA damage in rapidly dividing cancer cells and limits their ability to grow and multiply.
Common Side Effects
- Nausea and vomiting
- Diarrhea
- Fatigue and weakness
- Loss of appetite
- Hair loss
- Fever
- Headache
- Low white blood cell, red blood cell, or platelet counts
- Increased risk of infections
Important Information
Topotecan Injection IP should be administered only under the supervision of a qualified oncologist or healthcare professional. Regular blood tests are generally required because the medicine can cause significant decreases in blood cell counts, increasing the risk of infection, anemia, and bleeding. Inform your healthcare professional about any existing medical conditions, infections, or other medicines being used. Seek immediate medical attention for high fever, unusual bleeding or bruising, severe weakness, or signs of infection. Topotecan can cause serious fetal harm and should be used with appropriate pregnancy precautions as advised by the treating specialist.